The World Health Organization on Nov. 13, 2020, granted Emergency Use Listing to a novel oral polio vaccine, developed by the Bill & Melinda Gates Foundation. The vaccine is designed to treat type 2 vaccine-derived poliovirus — the same type of polio identified in the U.K.’s first polio outbreak in 40 years.